Epygenix Therapeutics is a precision medicine-based biopharmaceutical company focused on discovering and developing drugs that treat Dravet syndrome (DS) and other genetic epilepsies. DS is a rare and catastrophic form of intractable epilepsy that begins in infancy. Current therapeutic options are not effective, and the constant care required can severely impact quality of life for the entire family. Dravet syndrome, like most...
Epygenix Therapeutics is a precision medicine-based biopharmaceutical company focused on discovering and developing drugs that treat Dravet syndrome (DS) and other genetic epilepsies. DS is a rare and catastrophic form of intractable epilepsy that begins in infancy. Current therapeutic options are not effective, and the constant care required can severely impact quality of life for the entire family. Dravet syndrome, like most genetic forms of epilepsy, represents an orphan indication with an unmet medical need.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.